Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828262) titled 'The Use of Tranexamic Acid in Decreasing Wound Complication in Total Ankle Replacement. A Pilot Randomized Controlled Trial' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Ottawa Hospital Research Institute
Condition:
Ankle Arthritis
Wound Complication
Intervention:
Drug: Transexamic acid
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: December 2026
Target Sample Size: 40
Count...